Wolf Randi L, Cauley Jane A, Pettinger Mary, Jackson Rebecca, Lacroix Andrea, Leboff Meryl S, Lewis Cora E, Nevitt Michael C, Simon Joel A, Stone Katie L, Wactawski-Wende Jean
Program in Nutrition, Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY 10027, USA.
Am J Clin Nutr. 2005 Sep;82(3):581-8. doi: 10.1093/ajcn.82.3.581.
Antioxidant defenses are one possible mechanism for decreasing oxidative damage and its potentially negative effects on age-related bone mass.
This study cross-sectionally examined whether higher dietary intakes, total intakes, and serum concentrations of antioxidants may be associated with higher bone mineral density (BMD).
Total hip (and subregions), spine, and total-body BMDs were measured in 11,068 women aged 50-79 y enrolled in the Women's Health Initiative Observational Study and Clinical Trial at 3 clinics. Antioxidant intakes from diet (vitamin A, retinol, beta-carotene, vitamin C, vitamin E, and selenium) were estimated by using a self-reported food-frequency questionnaire. Antioxidants from supplements were estimated with an interviewer-administered questionnaire. A random subset (n = 379) had serum concentrations of retinol, carotenoids, and tocopherols measured.
After adjustment for important BMD-related covariates, increasing intakes of antioxidants were not independently associated with BMD. A significant interaction effect was observed between intake of total vitamin C (lower three-fourths compared with highest one-fourth) and use of hormone therapy (HT) (P < 0.01). The beneficial effect of current HT use on femoral neck BMD appeared to be greater in women with higher concentrations of total vitamin C. This interaction was also significant for total-body (P < 0.045), spine (P = 0.03), and total-hip BMDs (P = 0.029).
Our results do not support independent associations between dietary intake, total intake, or serum concentrations of antioxidants and BMD in women participating in the Women's Health Initiative. The extent to which HT use may interact with vitamin C intake and BMD warrants further exploration.
抗氧化防御是减少氧化损伤及其对与年龄相关的骨量潜在负面影响的一种可能机制。
本研究采用横断面研究方法,探讨较高的抗氧化剂膳食摄入量、总摄入量和血清浓度是否与较高的骨矿物质密度(BMD)相关。
在3家诊所对参加女性健康倡议观察性研究和临床试验的11068名50 - 79岁女性进行全髋(及亚区域)、脊柱和全身骨密度测量。通过使用自我报告的食物频率问卷估计饮食中的抗氧化剂摄入量(维生素A、视黄醇、β - 胡萝卜素、维生素C、维生素E和硒)。通过访谈者管理的问卷估计补充剂中的抗氧化剂摄入量。对一个随机子集(n = 379)测量血清视黄醇、类胡萝卜素和生育酚浓度。
在对重要的骨密度相关协变量进行调整后,抗氧化剂摄入量的增加与骨密度无独立相关性。观察到总维生素C摄入量(最低四分之三与最高四分之一相比)与激素治疗(HT)使用之间存在显著的交互作用(P < 0.01)。在总维生素C浓度较高的女性中,当前使用HT对股骨颈骨密度的有益作用似乎更大。这种交互作用在全身(P < 0.045)、脊柱(P = 0.03)和全髋骨密度(P = 0.029)方面也很显著。
我们的结果不支持参与女性健康倡议的女性中抗氧化剂的膳食摄入量、总摄入量或血清浓度与骨密度之间存在独立关联。HT使用与维生素C摄入量和骨密度之间相互作用的程度值得进一步探索。